SII Collaborates To Provide Equal Healthcare Rights To Trans Community

Adar Poonawalla, the CEO of Serum Institute of India (SII), the world’s most voluminous producer of vaccines, has said that SII would be collaborating with the transgender activist – Laxmi Narayan Tripathi, to ensure that the community is vaccinated. 

“I have always believed that healthcare and dignity should be fundamental human rights. I look forward to collaborate with @ImLaxmiNarayan in providing equal opportunities to the transgender community in India,” tweeted Adar Poonawalla, on 12th July, 2021. Up until June 2021, only 11.45% of the transgender population was partially vaccinated with one dose of the Covid-19 vaccine.

SII manufactures the Covishield vaccine, under licence from AstraZeneca, and is also preparing to use a local version of the Novavax vaccine. Most of the vaccines used in India are Covishield.

Leave a Reply